TY - JOUR
T1 - Effect of protein kinase C activation on N-methyl-D-aspartate-evoked release of adenosine and [3H]norepinephrine from rat cortical slices
AU - Wang, Yushan
AU - White, Thomas D.
PY - 1998/4
Y1 - 1998/4
N2 - The role of protein kinase C (PKC) in the N-methyl-D-aspartate (NMDA)- evoked release of adenosine (ADO) and [3H]norepinephrine (NE) from slices of rat parietal cortex was studied. In the absence of Mg++, the PKC activator phorbol 12-myristate 13-acetate (1 μM, PMA) did not release either ADO or [3H]NE, but it potentiated the release of ADO evoked by 20 μM NMDA and the release of [3H]NE evoked by 100 μM NMDA. These potentiating effects of PMA on the NMDA-evoked release of ADO and [3H]NE were reversed by the PKC inhibitor GF109,203X (1 μM). GF109,203X by itself had no effect on the NMDA- evoked release of either ADO or [3H]NE. In the presence of Mg++, PMA did not permit the NMDA-evoked release of [3H]NE to occur. These results indicate that PKC does not play an essential role in the NMDA-evoked release of either ADO or NE. However, activation of PKC potentiates the release of ADO and NE evoked by submaximal concentrations of NMDA. Activation of PKC will have the effect of increasing the inhibitory threshold provided by released ADO when only a few NMDA receptors are activated and will promote and accelerate excitatory responses when most of the available NMDA receptors become activated.
AB - The role of protein kinase C (PKC) in the N-methyl-D-aspartate (NMDA)- evoked release of adenosine (ADO) and [3H]norepinephrine (NE) from slices of rat parietal cortex was studied. In the absence of Mg++, the PKC activator phorbol 12-myristate 13-acetate (1 μM, PMA) did not release either ADO or [3H]NE, but it potentiated the release of ADO evoked by 20 μM NMDA and the release of [3H]NE evoked by 100 μM NMDA. These potentiating effects of PMA on the NMDA-evoked release of ADO and [3H]NE were reversed by the PKC inhibitor GF109,203X (1 μM). GF109,203X by itself had no effect on the NMDA- evoked release of either ADO or [3H]NE. In the presence of Mg++, PMA did not permit the NMDA-evoked release of [3H]NE to occur. These results indicate that PKC does not play an essential role in the NMDA-evoked release of either ADO or NE. However, activation of PKC potentiates the release of ADO and NE evoked by submaximal concentrations of NMDA. Activation of PKC will have the effect of increasing the inhibitory threshold provided by released ADO when only a few NMDA receptors are activated and will promote and accelerate excitatory responses when most of the available NMDA receptors become activated.
UR - http://www.scopus.com/inward/record.url?scp=0031969705&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031969705&partnerID=8YFLogxK
M3 - Article
C2 - 9535999
AN - SCOPUS:0031969705
SN - 0022-3565
VL - 285
SP - 105
EP - 109
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 1
ER -